Our Vision
To transform Barbados into the trusted pharmaceutical manufacturing gateway for the Caribbean and the Global South.
Local production of essential medicines, starting with IV fluids, scaling to ARVs, diagnostics, and NCDs.
A regional logistics model that puts medicines where they are needed, reliably and at lower cost.
The regulatory, workforce, and institutional foundations that sustain a pharmaceutical sector for generations.
Our Mission
To accelerate access to high-quality, affordable medicines across the Caribbean by building a resilient pharmaceutical industry, attracting global investment, and positioning Barbados as the gateway to the region and beyond.
By the Numbers
In three years, BPI has gone from a founding mandate to five bankable projects and the first pharmaceutical trade corridor between Africa and the Caribbean.
Total investment in the AMA IV fluids manufacturing facility at Grantley Adams Industrial Estate.
Bags of IV fluids to be produced annually, the first of their kind manufactured in the Caribbean.
Lives touched by the PAHO revolving fund that BPI's regional supply hub will support.
EU PharmaNext investment mobilized to build a transatlantic pharmaceutical investment bridge.
Where Investment Meets Execution
Initiatives
- AMA IV Fluids Manufacturing
Grantley Adams Industrial EstateThe first Africa–Caribbean pharmaceutical trade corridor. 12 million units annually. A corridor, not a pilot.
- PAHO Regional Supply Hub
Serving 40+ countries across the Caribbean and Latin America.
- EU PharmaNext
€3M transatlantic pharmaceutical investment bridge.
- BMPRA Regulatory Development
Barbados's own standard-holder, built with WHO and PAHO.
Leadership
BPI is led by a team of global health strategists, investment specialists, and pharmaceutical sector experts united by a single mandate.